| Virginia Osusa Figueroa, MD | |
|
University District Hospital, Medical Center Udh 2 Po 2116, San Juan, PR 00922-2116 | |
| (787) 758-0640 | |
| Not Available |
| Full Name | Virginia Osusa Figueroa |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 17 Years |
| Location | University District Hospital, San Juan, Puerto Rico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154585933 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 11990I (Puerto Rico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Presbyterian Community Hosp | San juan, PR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Presbyterian Medical Anesthesia Group | 6800027053 | 5 |
News Archive
Over the course of a lifetime, the heart pumps some 250 million liters of blood through the body. In the order to do this, the muscle fibers of the heart have to be extremely durable. The research group headed by Dr. Wolfgang Rottbauer, vice chair of the Department of Medicine III at Heidelberg University Hospital (Chairman: Prof. Dr. H. A. Katus), has discovered a protein that is responsible for the stability of the smallest muscular unit, the sarcomere.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that the Company has initiated patient dosing in a Phase II clinical trial of ACH-1625 for the treatment of hepatitis C virus (HCV) infection. ACH-1625 is a potent small molecule inhibitor of HCV protease, an enzyme necessary for viral replication. The drug candidate was discovered and is being advanced by Achillion.
Speaker Nancy Pelosi, House Democratic Leaders, Committee Chairs, Members of Congress and Americans who are struggling under the current health care system held a rally on the West Front of the Capitol this morning to unveil H.R. 3962, the Affordable Health Care for America Act. Below are the Speaker's opening remarks.
In 2006, the lab of Dr. David Ginsburg at the Life Sciences Institute put a call out for siblings attending the University of Michigan to donate blood for a study of blood-clotting disorders.
The effort, by Reps. Schwartz and Heck, would change the system known as the sustainable growth rate for Medicare physician payments.
› Verified 5 days ago
| Entity Name | Presbyterian Medical Anesthesia Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851376040 PECOS PAC ID: 6800027053 Enrollment ID: O20140401001158 |
News Archive
Over the course of a lifetime, the heart pumps some 250 million liters of blood through the body. In the order to do this, the muscle fibers of the heart have to be extremely durable. The research group headed by Dr. Wolfgang Rottbauer, vice chair of the Department of Medicine III at Heidelberg University Hospital (Chairman: Prof. Dr. H. A. Katus), has discovered a protein that is responsible for the stability of the smallest muscular unit, the sarcomere.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that the Company has initiated patient dosing in a Phase II clinical trial of ACH-1625 for the treatment of hepatitis C virus (HCV) infection. ACH-1625 is a potent small molecule inhibitor of HCV protease, an enzyme necessary for viral replication. The drug candidate was discovered and is being advanced by Achillion.
Speaker Nancy Pelosi, House Democratic Leaders, Committee Chairs, Members of Congress and Americans who are struggling under the current health care system held a rally on the West Front of the Capitol this morning to unveil H.R. 3962, the Affordable Health Care for America Act. Below are the Speaker's opening remarks.
In 2006, the lab of Dr. David Ginsburg at the Life Sciences Institute put a call out for siblings attending the University of Michigan to donate blood for a study of blood-clotting disorders.
The effort, by Reps. Schwartz and Heck, would change the system known as the sustainable growth rate for Medicare physician payments.
› Verified 5 days ago
| Entity Name | Centro De Cancer De La Universidad |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215418751 PECOS PAC ID: 7113220385 Enrollment ID: O20210318001999 |
News Archive
Over the course of a lifetime, the heart pumps some 250 million liters of blood through the body. In the order to do this, the muscle fibers of the heart have to be extremely durable. The research group headed by Dr. Wolfgang Rottbauer, vice chair of the Department of Medicine III at Heidelberg University Hospital (Chairman: Prof. Dr. H. A. Katus), has discovered a protein that is responsible for the stability of the smallest muscular unit, the sarcomere.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that the Company has initiated patient dosing in a Phase II clinical trial of ACH-1625 for the treatment of hepatitis C virus (HCV) infection. ACH-1625 is a potent small molecule inhibitor of HCV protease, an enzyme necessary for viral replication. The drug candidate was discovered and is being advanced by Achillion.
Speaker Nancy Pelosi, House Democratic Leaders, Committee Chairs, Members of Congress and Americans who are struggling under the current health care system held a rally on the West Front of the Capitol this morning to unveil H.R. 3962, the Affordable Health Care for America Act. Below are the Speaker's opening remarks.
In 2006, the lab of Dr. David Ginsburg at the Life Sciences Institute put a call out for siblings attending the University of Michigan to donate blood for a study of blood-clotting disorders.
The effort, by Reps. Schwartz and Heck, would change the system known as the sustainable growth rate for Medicare physician payments.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Virginia Osusa Figueroa, MD University District Hospital, Medical Center Udh 2 Po 2116, San Juan, PR 00922-2116 Ph: (787) 758-0640 | Virginia Osusa Figueroa, MD University District Hospital, Medical Center Udh 2 Po 2116, San Juan, PR 00922-2116 Ph: (787) 758-0640 |
News Archive
Over the course of a lifetime, the heart pumps some 250 million liters of blood through the body. In the order to do this, the muscle fibers of the heart have to be extremely durable. The research group headed by Dr. Wolfgang Rottbauer, vice chair of the Department of Medicine III at Heidelberg University Hospital (Chairman: Prof. Dr. H. A. Katus), has discovered a protein that is responsible for the stability of the smallest muscular unit, the sarcomere.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that the Company has initiated patient dosing in a Phase II clinical trial of ACH-1625 for the treatment of hepatitis C virus (HCV) infection. ACH-1625 is a potent small molecule inhibitor of HCV protease, an enzyme necessary for viral replication. The drug candidate was discovered and is being advanced by Achillion.
Speaker Nancy Pelosi, House Democratic Leaders, Committee Chairs, Members of Congress and Americans who are struggling under the current health care system held a rally on the West Front of the Capitol this morning to unveil H.R. 3962, the Affordable Health Care for America Act. Below are the Speaker's opening remarks.
In 2006, the lab of Dr. David Ginsburg at the Life Sciences Institute put a call out for siblings attending the University of Michigan to donate blood for a study of blood-clotting disorders.
The effort, by Reps. Schwartz and Heck, would change the system known as the sustainable growth rate for Medicare physician payments.
› Verified 5 days ago
Dr. Jose R. Ortiz-cardona, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: Anestesiologia Rcm, Suite 989 Edif Principal Ciencias Medicas, San Juan, PR 00936 Phone: 787-758-0640 Fax: 787-758-1327 | |
Antonio J Mattei Pacheco, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 150 Ave De Diego, Suite 300 Edif. San Juan Health Centre, San Juan, PR 00907 Phone: 787-729-0606 Fax: 787-729-4242 | |
Dr. Belisario Matta De Juan Sr., M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: Ashford Avenue 1357, Suite 2 Pmb 423, San Juan, PR 00907 Phone: 787-725-7860 Fax: 787-722-3630 | |
Dr. Angel M Vazquez Alvarez, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 400 Fd.roosevelt Ave. Clinica Las Americas Suite 301, San Juan, PR 00918 Phone: 787-756-8418 Fax: 787-250-8597 | |
Dr. Lymari Vargas-rivera, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 550 Calle Sergio Cuevas, San Juan, PR 00918 Phone: 787-407-1615 Fax: 787-759-0101 | |
Linka Matos Rivera, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: Ave Pinero # 291, San Juan, PR 00918 Phone: 787-430-7246 Fax: 939-338-0885 | |
Mr. Ricardo Feliciano Valera, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 258 Calle San Jorge, San Juan, PR 00912 Phone: 787-728-6902 Fax: 787-728-6902 |